Wu-Mei-Wan Reduces Insulin Resistance via Inhibition of NLRP3 Inflammasome Activation in HepG2 Cells

Figure 2

Effects of the medicated serum of WMW on cell proliferation in palmitate-treated HepG2 cells. HepG2 cells were treated with 0.25 mM palmitate for 24 h, and normal serum without WMW (N) or medicated serum containing low (L), middle (M), or high (H) dose of WMW was then added for 24 h. The number of viable cells was examined by the MTT assay.